These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Treatment and prevention of nonsteroidal anti-inflammatory drug induced gastrointestinal mucosal injury. Agrawal NM; Dajani EZ Int J Clin Pharmacol Res; 1989; 9(6):347-57. PubMed ID: 2576801 [TBL] [Abstract][Full Text] [Related]
8. [Pharmacological inhibition of gastric secretion and treatment of peptic ulcer]. Konturek SJ Rev Esp Enferm Apar Dig; 1978 Apr; 53(1):65-82. PubMed ID: 26940 [No Abstract] [Full Text] [Related]
9. [Non-proteolytic enzymes of human gastric and duodenal mucosa in peptic ulcer]. Ivanov GG Vopr Med Khim; 1976; 22(3):339-42. PubMed ID: 1030892 [TBL] [Abstract][Full Text] [Related]
10. [On the isoenzymatic aspect of the digestive mucosa. Experimental and clinical study]. Chiriloiu C; Zamfirescu-Gheorghiu M; Matei M Stud Cercet Med Interna; 1971; 12(1):61-5. PubMed ID: 5565780 [No Abstract] [Full Text] [Related]
11. [Perspectives in the drug therapy of peptic ulcer]. Kamada T; Sato N; Kawano S Nihon Rinsho; 1988 Jan; 46(1):7-11. PubMed ID: 2897487 [No Abstract] [Full Text] [Related]
12. [Antirheumatic drug-induced damage of the gastroduodenal mucosa: approach to prevention]. Domschke S; Domschke W Internist (Berl); 1986 Oct; 27(10):630-6. PubMed ID: 2878905 [No Abstract] [Full Text] [Related]
13. Adenylate cyclase of human gastric mucosa. Stimulation of enzyme activity by histamine and catecholamines. Simon B; Kather H Digestion; 1977; 16(1-2):175-9. PubMed ID: 28260 [TBL] [Abstract][Full Text] [Related]
14. [Distribution and properties of the alkaline phosphatase in the human gastric mucosa in peptic ulcer]. Ivanov GG Vopr Med Khim; 1978; 24(2):206-10. PubMed ID: 664446 [TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal mucosal gamma-glutamyl transpeptidase activity changes in different ulcer models of rat. Náfrádi J; Balint GA; Csáti S; Varró V Agents Actions; 1984 Dec; 15(5-6):549-50. PubMed ID: 6152378 [TBL] [Abstract][Full Text] [Related]
16. [New class of pharmacological preparations: histamine H2-receptors blockaders (a review of the literature)]. Ionov ID Farmakol Toksikol; 1978; 41(5):624-32. PubMed ID: 81139 [No Abstract] [Full Text] [Related]
17. Histamine H2-receptor antagonists in peptic ulcer disease. Evidence for a prophylactic use. Nash J; Lambert L; Deakin M Drugs; 1994 Jun; 47(6):862-71. PubMed ID: 7521828 [TBL] [Abstract][Full Text] [Related]
18. Mucosa protectives: sucralfate and colloidal bismuth subcitrate in peptic ulcer disease. Tytgat GN; Nio CY Z Gastroenterol; 1987 Aug; 25 Suppl 3():152-61. PubMed ID: 3660894 [TBL] [Abstract][Full Text] [Related]
19. [Histamine and its role in peptic gastric diseases: the discovery of histamine-H2-receptor antagonists]. Barth H; Lorenz W Acta Med Austriaca; 1978; 5(2):25-31. PubMed ID: 32719 [TBL] [Abstract][Full Text] [Related]
20. NSAID-induced peptic ulcer disease: a critical review of pathogenesis and management. Scheiman JM Dig Dis; 1994; 12(4):210-22. PubMed ID: 7851000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]